His programme combines the drugs rosuvastatin, hydrochlorothiazide, amlopidine and losartan. It claims to lower the risk of a heart attack or stroke by two thirds. Almost two million people in ...

“The status quo is not a justifiable option.” His programme combines the drugs rosuvastatin, hydrochlorothiazide, amlopidine and losartan. It claims to lower the risk of a heart attack or ...

The status quo is not a justifiable option.” His programme combines the drugs rosuvastatin, hydrochlorothiazide, amlopidine and losartan. It claims to lower the risk of a heart attack or stroke ...

AT-II-receptor antagonists include losartan, valsartan ... any clinically important interactions with digoxin, warfarin, and hydrochlorothiazide. All available AT-II-receptor antagonists seem ...

This resulted in additional recalls of Valsartan, and losartan-containing products ... recalled four batches of the Irbesartan/Hydrochlorothiazide made by Actavis, as a 'precautionary measure ...

High blood pressure, or hypertension, is a common condition that affects millions of people worldwide. To prevent serious complications like heart attacks, strokes, and kidney dis ...

Blood pressure - may be losartan or hydrochlorothiazide if he’s not already on one and if he has diabetes or not. He should be on aspirin and clopidogrel.” "Abeg make I ask, Is AGN not suppose to have ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...